New Study Shows Psilocybin May Be Effective in Treating Anorexia Nervosa | Psychedelic Spotlight

Extracts from Ganoderma resinaceum mushrooms, including amadou (Fomes) and reishi (Ganoderma) fungi, significantly reduced instances of deformed wing virus (DWF) and Lake Sinai virus (LSV) in honey bee colonies, leading to an extended lifespan for the bees.

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants – Psychedelic Alpha

VLS-01, a proprietary oral transmucosal film (OTF) formulation of DMT, was well-tolerated with a favorable safety profile Pharmacokinetic and pharmacodynamic data confirmed systemic delivery of

October 3, 2023

Indiana Advances Psilocybin Research with New Funding Initiative | Psychedelic Invest

Governor Eric Holcomb of Indiana has recently enacted a law that earmarks funds for clinical trials to explore the therapeutic effects of psilocybin. This development

April 12, 2024

DOJ Charges Dozens of Doctors, NPs in $2.7 Billion Healthcare Fraud Crackdown

Nearly 200 people have been charged in a sweeping nationwide crackdown on healthcare fraud schemes with false claims topping $2.7 billion, the Justice Department said

June 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.